Kazantsev A, Mu D, Nichols A F, Zhao X, Linn S, Sancar A
Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7260, USA.
Proc Natl Acad Sci U S A. 1996 May 14;93(10):5014-8. doi: 10.1073/pnas.93.10.5014.
Xeroderma pigmentosum (XP) is caused by a defect in nucleotide excision repair. Patients in the complementation group E (XP-E) have the mildest form of the disease and the highest level of residual repair activity. About 20% of the cell strains derived from XP-E patients lack a damaged DNA-binding protein (DDB) activity that binds to ultraviolet-induced (6-4) photoproducts with high affinity. We report here that cell-free extracts prepared from XP-E cell strains that either lacked or contained DDB activity were severely defective in excising DNA damage including (6-4) photoproducts. However, this excision activity defect was not restored by addition of purified DDB that, in fact, inhibited removal of (6-4) photoproducts by the human excision nuclease reconstituted from purified proteins. Extensive purification of correcting activity from HeLa cells revealed that the correcting activity is inseparable from the human replication/repair protein A [RPA (also known as human single stranded DNA binding protein, HSSB)]. Indeed, supplementing XP-E extracts with recombinant human RPA purified from Escherichia coli restored excision activity. However, no mutation was found in the genes encoding the three subunits of RPA in an XP-E (DDB-) cell line. It is concluded that RPA functionally complements XP-E extracts in vitro, but it is not genetically altered in XP-E patients.
着色性干皮病(XP)是由核苷酸切除修复缺陷引起的。互补组E(XP-E)的患者患有该病最轻微的形式,且具有最高水平的残余修复活性。约20%源自XP-E患者的细胞株缺乏一种能与紫外线诱导的(6-4)光产物高亲和力结合的受损DNA结合蛋白(DDB)活性。我们在此报告,从缺乏或含有DDB活性的XP-E细胞株制备的无细胞提取物在切除包括(6-4)光产物在内的DNA损伤方面存在严重缺陷。然而,添加纯化的DDB并不能恢复这种切除活性缺陷,事实上,纯化的DDB会抑制由纯化蛋白重构的人切除核酸酶对(6-4)光产物的去除。从HeLa细胞中广泛纯化校正活性表明,校正活性与人类复制/修复蛋白A [RPA(也称为人类单链DNA结合蛋白,HSSB)] 不可分离。实际上,用从大肠杆菌纯化的重组人RPA补充XP-E提取物可恢复切除活性。然而,在一个XP-E(DDB-)细胞系中,编码RPA三个亚基的基因未发现突变。结论是,RPA在体外对XP-E提取物具有功能互补作用,但在XP-E患者中其基因未发生改变。